105 results
Page 4 of 6
8-K
EX-99.1
r6xnqjtw8ese9c 0cjo
9 Aug 21
Pulse Biosciences Reports Second Quarter 2021 Financial Results
4:32pm
8-K
EX-99.1
kek4qlvqelvi7east
1 Jul 21
Pulse Biosciences Announces $50 Million Private Placement
8:33am
8-K
EX-99.1
qqv065458om7fs0xuocm
9 Jun 21
Pulse Biosciences Announces Health Canada Approval for CellFX® System
8:22am
SD
EX-1.01
04cuy 29oh21c1bz
28 May 21
Conflict minerals disclosure
4:41pm
8-K
EX-99.1
070vlhp26s5iyku
10 May 21
Pulse Biosciences Reports First Quarter 2021 Financial Results
4:23pm
8-K
EX-99.1
rzxta
22 Feb 21
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
424B5
9hb00dqr2a5 t36mc1
4 Feb 21
Prospectus supplement for primary offering
8:46am
8-K
EX-99.1
yvyu3
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-99.1
1eo6ij6niys1aefy
3 Feb 21
Pulse Biosciences Announces FDA Clearance for the CellFX® System
4:13pm
8-K
EX-99.1
n9awl
25 Jan 21
Pulse Biosciences Announces CE Mark Approval for CellFX® System
8:12am
8-K
EX-99.1
fuuwpl
5 Jan 21
Pulse Biosciences, Inc. Announces Redemption of Warrants
9:16am
8-K
EX-99.1
up299x6tvj1 li
9 Nov 20
Pulse Biosciences Reports Third Quarter 2020 Financial Results
4:29pm
8-K
EX-99.1
yponndxbts
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm
8-K
EX-99.1
w2fc n8xq4
6 Aug 20
Pulse Biosciences, Inc. Appoints Richard van den Broek to Board of Directors
5:00pm